. Author manuscript; available in PMC: 2013 Jan 3.

Published in final edited form as: J Endocrinol Metab. 2012 Apr 1;2(2):51–65. doi: 10.4021/jem95W

Table 5.

Association Between MHO Phenotype and Adiponectin Levels Among African Americans in Logistic Regression Models with Adjustment for Relevant Covariates.

Dependent variable: MHO (yes=1; no=0)
Gender	PHA: yes/no (covariates)	B ± S.E.	OR (95% CI)

Men	PHA^¥	1.01±0.50	2.8 (1.03-7.40)
	PHA^¥ (age)	1.10±0.51	2.9 (1.1-7.80)
	PHA^¥ (age, HTN)	1.30±0.56	3.5 (1.2-10.55)
	PHA^¥ (age, HTN, WC)	1.20±0.57	3.3 (1.1-10.02)
	PHA^¥(age, HTN, WC, INS)	1.30±0.59	3.6 (1.1-11.5)

Women	PHA^¥	0.72±0.35	2.1 (1.04-4.10)
	PHA^¥ (age)	0.80±0.4	2.2 (1.10-4.51)
	PHA^¥ (age, HTN)	0.90±0.39	2.4 (1.10-5.03)
	PHA^¥ (age, HTN, WC)	0.65±0.40	1.9 (0.90-4.20)
	PHA^¥, (age, HTN, WC, INS)	0.61±0.41	1.8 (0.80-4.12)

B: coefficient, S.E. standard error of B, OR: estimated odds ratio, CI: confidence interval of OR; HTN: hypertension (0= no hypertension, 1= hypertension), WC=waist circumference, INS= log- insulin

^¥

PHA status was coded 1, if adiponectin level is above 8377.2 ng/ml and 11050.9 ng/ml for men and women respectively; or 0, if adiponectin level is below 8377.2 ng/ml and 11050.9 ng/ml for men and women respectively.

* Denote significant p-value (p < 0.05)